bpc 157 3rd party tested BPC-157 — Technical Lot Record · Lyos Labs Rpl BPC-157 RESEARCH PEPTIDE 1,000

Clinical Relevance and Human Trials Clinical trials have explored the administration of BPC 157 at a dosage of 200 g per person per day via intramuscular injection for a duration of 7 days

Rehydrate to allow the body to process and distribute the injection

If there is a change in ECF osmolarity, then a water shift must occur

MenonSNasirBAvganNGhassabianSOliverCLeaRet al

c , e , Exponential-phase ( c ) and stationary-phase ( e ) cultures were treated with and without 40 M KL1 and 2 g/mL Rif for 24 h, followed by a wash step and plating to enumerate surviving bacteria

for acute deficiency, treatment may continue until clinical signs resolve and laboratory values normalize